Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianna Traugott

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
BMJ Open|March 8, 2022
Occupational challenges of healthcare workers during the COVID-19 pandemic: a qualitative studyMaren Jeleff, Marianna Traugott, Elena Jirovsky-Platter, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|March 29, 2022
[Diagnosis and treatment of COVID-19 in intensive care units]Wolfgang Hoepler, Marianna Traugott, Alexander Zoufaly, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 27, 2021
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19Hannes Vietzen, Alexander Zoufaly, Marianna Traugott, et al.
Microbiology Spectrum|June 13, 2022
Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19Tamara Seitz, Johannes Holbik, Julian Hind, et al.
Journal of Medical Virology|December 14, 2022
The natural killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19Hannes Vietzen, Philippe L Furlano, Marianna Traugott, et al.
The Journal of Infectious Diseases|May 31, 2020
Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid TestsMarianna Traugott, Stephan Walter Aberle, Judith Helene Aberle, et al.
Frontiers in Pharmacology|July 19, 2021
High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19Mario Karolyi, Sara Omid, Erich Pawelka, et al.
Journal of Infection and Public Health|July 12, 2023
SARS-CoV-2 infections in "less visible" hospital staff: The roles and safety of environmental services and allied health professionalsSebastian Jensen, Marianna Traugott, Dariga Ramazanova, et al.
The Lancet. Rheumatology|October 17, 2022
Monkeypox associated acute arthritisMirella Fonti, Theresa Mader, Jan Burmester-Kiang, et al.
BMJ Open|October 11, 2022
Experiences and challenges faced by patients with COVID-19 who were hospitalised and participated in a randomised controlled trial: a qualitative studyLukas Hofstetter, Viktoria Tinhof, Hannah Mayfurth, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
BMJ Open|March 8, 2022
Occupational challenges of healthcare workers during the COVID-19 pandemic: a qualitative studyMaren Jeleff, Marianna Traugott, Elena Jirovsky-Platter, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|March 29, 2022
[Diagnosis and treatment of COVID-19 in intensive care units]Wolfgang Hoepler, Marianna Traugott, Alexander Zoufaly, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 27, 2021
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19Hannes Vietzen, Alexander Zoufaly, Marianna Traugott, et al.
Microbiology Spectrum|June 13, 2022
Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19Tamara Seitz, Johannes Holbik, Julian Hind, et al.
Journal of Medical Virology|December 14, 2022
The natural killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19Hannes Vietzen, Philippe L Furlano, Marianna Traugott, et al.
The Journal of Infectious Diseases|May 31, 2020
Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid TestsMarianna Traugott, Stephan Walter Aberle, Judith Helene Aberle, et al.
Frontiers in Pharmacology|July 19, 2021
High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19Mario Karolyi, Sara Omid, Erich Pawelka, et al.
Journal of Infection and Public Health|July 12, 2023
SARS-CoV-2 infections in "less visible" hospital staff: The roles and safety of environmental services and allied health professionalsSebastian Jensen, Marianna Traugott, Dariga Ramazanova, et al.
The Lancet. Rheumatology|October 17, 2022
Monkeypox associated acute arthritisMirella Fonti, Theresa Mader, Jan Burmester-Kiang, et al.
BMJ Open|October 11, 2022
Experiences and challenges faced by patients with COVID-19 who were hospitalised and participated in a randomised controlled trial: a qualitative studyLukas Hofstetter, Viktoria Tinhof, Hannah Mayfurth, et al.
Pageof 3